590 related articles for article (PubMed ID: 24485975)
21. Bone scans, bisphosphonates, and a lack of acute changes within the mandible.
Morris PG; Hudis C; Carrasquillo J; Larson S; Grewal RK; Van Poznak C
J Oral Maxillofac Surg; 2011 Jan; 69(1):114-9. PubMed ID: 21056922
[TBL] [Abstract][Full Text] [Related]
22. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw.
Ohbayashi Y; Miyake M; Sawai F; Minami Y; Iwasaki A; Matsui Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):e31-7. PubMed ID: 23246226
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: similarities with phossy jaw.
Campisi G; Compilato D; Angelo I; Lo Muzio L; Colella G
Indian J Dent Res; 2012; 23(5):683-5. PubMed ID: 23422621
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.
Saia G; Blandamura S; Bettini G; Tronchet A; Totola A; Bedogni G; Ferronato G; Nocini PF; Bedogni A
J Oral Maxillofac Surg; 2010 Apr; 68(4):797-804. PubMed ID: 20307765
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw.
Yin G; Bai Y; Luo E
Med Hypotheses; 2011 Mar; 76(3):347-9. PubMed ID: 21074946
[TBL] [Abstract][Full Text] [Related]
27. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
Sidhu HK
Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Piccioli A
Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):29-37. PubMed ID: 24037511
[TBL] [Abstract][Full Text] [Related]
30. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
Krishnan A; Arslanoglu A; Yildirm N; Silbergleit R; Aygun N
J Comput Assist Tomogr; 2009; 33(2):298-304. PubMed ID: 19346864
[TBL] [Abstract][Full Text] [Related]
31. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
Udvardy E; Redl P; Márton I
Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate-related osteonecrosis of the skull base.
Khan AM; Sindwani R
Laryngoscope; 2009 Mar; 119(3):449-52. PubMed ID: 19235747
[TBL] [Abstract][Full Text] [Related]
33. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
34. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
Ishikawa T
Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
[TBL] [Abstract][Full Text] [Related]
35. The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study.
Dayisoylu EH; Şenel FÇ; Üngör C; Tosun E; Çankaya M; Ersöz S; Taskesen F
Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1475-80. PubMed ID: 23746422
[TBL] [Abstract][Full Text] [Related]
36. Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates.
Rocha GC; Jaguar GC; Moreira CR; Neves EG; Fonseca FP; Pedreira EN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5 Suppl):S19-25. PubMed ID: 23083951
[TBL] [Abstract][Full Text] [Related]
37. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
Mori M; Koide T; Matsui Y; Matsuda T
Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?
Pichardo SE; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):287-92. PubMed ID: 23953415
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
40. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
Loyson T; Van Cann T; Schöffski P; Clement PM; Bechter O; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B
Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
